Second-line combination chemotherapy with docetaxel and nedaplatin for Cisplatin-pretreated refractory metastatic/recurrent esophageal squamous cell carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/19542899

Download in:

View as

General Info

PMID
19542899